LENZ — Lenz Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for Lenz Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	19.8	377	268	184	209
Prepaid Expenses
Total Other Current Assets
Total Current Assets	21.1	382	275	188	212
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.46	18.1	28.2	0.321	1.99
Long Term Investments
Other Long Term Assets
Total Assets	22.6	402	322	188	215
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	32	12.1	13	4.8	10.4
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	32.4	17.9	25.6	4.87	11.2
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-9.8	384	296	184	204
Total Liabilities & Shareholders' Equity	22.6	402	322	188	215
Total Common Shares Outstanding